Bio-Techne Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve Its ProteinSimple proteomic analytical tools and Advanced Cell Diagnostics tissue biopsy products were standouts in the quarter, Bio-Techne's CEO said. New Products Posted to GenomeWeb: Pacific Biosciences, Paragon Genomics, Bio-Techne, More In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences News items for the week of April 5, 2021. Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test The firm said it will begin running its urine-based test immediately in its clinical laboratory in Munich and make it available throughout Europe. Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy Premium Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise. Mar 3, 2021 Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M Mar 1, 2021 Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test Feb 2, 2021 Bio-Techne Fiscal Q2 Revenues Rise 21 Percent Jan 14, 2021 JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Dec 2, 2020 Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment Nov 5, 2020 Bio-Techne Fiscal Q1 Revenues Rise 11 Percent on Diagnostics and Genomics Sales Sep 17, 2020 Bio-Techne, Qiagen Expand Partnership on Exosome Technology Aug 24, 2020 Inflammatory Cytokine Biomarkers Predict COVID-19 Survival, Could Yield Dx, Rx Targets Aug 21, 2020 New Products Posted to GenomeWeb: Thermo Fisher, Qiagen, Bio-Techne, More Aug 4, 2020 Bio-Techne Q4 Revenues Drop 8 Percent Jun 12, 2020 In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More May 26, 2020 Bio-Techne, Leica Biosystems Receive CE Mark for Pathology Detection Kit, Platform May 20, 2020 Bio-Techne Bets Clinical Utility Study Data Will Sway Payors to Cover Prostate Cancer Risk Test Premium Apr 30, 2020 Bio-Techne Fiscal Q3 Revenues Rise 5 Percent Despite Coronavirus Challenges Mar 18, 2020 Bio-Techne Lands Government Contract for Genomic Prostate Cancer Test Feb 4, 2020 Bio-Techne FY Q2 Revenues Rise 6 Percent, Miss Analysts' Estimate Oct 29, 2019 Bio-Techne Fiscal Q1 Revenues Rise 12 Percent Oct 10, 2019 Bio-Techne Receives Medicare Coverage for Prostate Cancer Test Aug 6, 2019 Bio-Techne's Fiscal Q4 Revenues Rise 6 Percent; Firm Misses Wall Street Estimates Jun 13, 2019 Bio-Techne Gets New York State Approval for Prostate Cancer Test Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.